|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marth C, Landoni F, Mahner S, McCormack M,
Gonzalez-Martin A and Colombo N: Cervical cancer: ESMO clinical
practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 28:iv72–iv83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seoud M, Tjalma WA and Ronsse V: Cervical
adenocarcinoma: Moving towards better prevention. Vaccine.
29:9148–9158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsukura T and Sugase M: Pitfalls in the
epidemiologic classification of human papillomavirus types
associated with cervical cancer using polymerase chain reaction:
Driver and passenger. Int J Gynecol Cancer. 18:1042–1050. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi X, Yuan N, Zhang S, Yuan F and Wang X:
MicroRNA-379 suppresses cervical cancer cell proliferation and
invasion by directly targeting V-crk avian sarcoma virus CT10
oncogene homolog-like. Oncol Res. Jan 2–2018.(Epub ahead of print).
doi: 10.3727/096504017X15140534417184. View Article : Google Scholar
|
|
13
|
Teng P, Jiao Y, Hao M and Tang X:
microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to
inhibit development of cervical cancer via down-regulating PARP2. J
Cell Biochem. 119:5243–5252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou LL, Shen Y, Gong JM, Sun P and Sheng
JH: MicroRNA-466 with tumor markers for cervical cancer screening.
Oncotarget. 8:70821–70827. 2017.PubMed/NCBI
|
|
15
|
Wang Z, He S, Guo P, Guo X and Zheng J:
MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal
transition by targeting AEG-1 in cervical cancer. Oncol Rep.
38:3121–3129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mei J, Wang DH, Wang LL, Chen Q, Pan LL
and Xia L: MicroRNA-200c suppressed cervical cancer cell metastasis
and growth via targeting MAP4K4. Eur Rev Med Pharmacol Sci.
22:623–631. 2018.PubMed/NCBI
|
|
17
|
Zhang Z, Wang J, Wang X, Song W, Shi Y and
Zhang L: MicroRNA-21 promotes proliferation, migration, and
invasion of cervical cancer through targeting TIMP3. Arch Gynecol
Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han J, Liu Z, Wang N and Pan W:
MicroRNA-874 inhibits growth, induces apoptosis and reverses
chemoresistance in colorectal cancer by targeting X-linked
inhibitor of apoptosis protein. Oncol Rep. 36:542–550. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong D, Gong Y, Zhang D, Bao H and Gu G:
miR-874 suppresses the proliferation and metastasis of osteosarcoma
by targeting E2F3. Tumour Biol. 37:6447–6455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Wei Y, Li X, Liang X, Wang L,
Song J, Zhang X, Zhang C, Niu J, Zhang P, et al: microRNA-874
suppresses tumor proliferation and metastasis in hepatocellular
carcinoma by targeting the DOR/EGFR/ERK pathway. Cell Death Dis.
9:1302018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang B, Li Z, Zhang W, Wang H, Zhi X,
Feng J, Chen Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 inhibits cell
proliferation, migration and invasion through targeting aquaporin-3
in gastric cancer. J Gastroenterol. 49:1011–1025. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Granados-López AJ, Ruiz-Carrillo JL,
Servín-González LS, Martínez-Rodríguez JL, Reyes-Estrada CA,
Gutiérrez-Hernández R and López JA: Use of mature miRNA strand
selection in miRNAs families in cervical cancer development. Int J
Mol Sci. 18:E4072017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Liu Q, Clark LH, Qiu H, Bae-Jump VL
and Zhou C: Deregulated miRNAs in human cervical cancer: Functional
importance and potential clinical use. Future Oncol. 13:743–753.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai S, Lu Y, Long Y, Lai Y, Du P, Ding N
and Yao D: Prognostic value of microRNAs in cervical carcinoma: A
systematic review and meta-analysis. Oncotarget. 7:35369–35378.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao B and Dong AS: MiR-874 inhibits cell
growth and induces apoptosis by targeting STAT3 in human colorectal
cancer cells. Eur Rev Med Pharmacol Sci. 20:269–277.
2016.PubMed/NCBI
|
|
27
|
Que K, Tong Y, Que G, Li L, Lin H, Huang
S, Wang R and Tang L: Downregulation of miR-874-3p promotes
chemotherapeutic resistance in colorectal cancer via inactivation
of the Hippo signaling pathway. Oncol Rep. 38:3376–3386.
2017.PubMed/NCBI
|
|
28
|
Jiang T, Guan LY, Ye YS, Liu HY and Li R:
MiR-874 inhibits metastasis and epithelial-mesenchymal transition
in hepatocellular carcinoma by targeting SOX12. Am J Cancer Res.
7:1310–1321. 2017.PubMed/NCBI
|
|
29
|
Leong KW, Cheng CW, Wong CM, Ng IO, Kwong
YL and Tse E: miR-874-3p is down-regulated in hepatocellular
carcinoma and negatively regulates PIN1 expression. Oncotarget.
8:11343–11355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Tang J, Zhi X, Xie K, Wang W, Li
Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor
suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway
in gastric cancer. Oncotarget. 6:1605–1617. 2015.PubMed/NCBI
|
|
31
|
Lin Z, Liu Y, Sun Y and He X: Expression
of Ets-1, Ang-2 and maspin in ovarian cancer and their role in
tumor angiogenesis. J Exp Clin Cancer Res. 30:312011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tokuhara K, Ogata Y, Nakagawa M and
Shirouzu K: Ets-1 expression in vascular endothelial cells as an
angiogenic and prognostic factor in colorectal carcinoma. Int Surg.
88:25–33. 2003.PubMed/NCBI
|
|
33
|
Xu S, Ge J, Zhang Z and Zhou W: MiR-129
inhibits cell proliferation and metastasis by targeting ETS1 via
PI3K/AKT/mTOR pathway in prostate cancer. Biomed Pharmacother.
96:634–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng L, Qi T, Yang D, Qi M, Li D, Xiang
X, Huang K and Tong Q: microRNA-9 suppresses the proliferation,
invasion and metastasis of gastric cancer cells through targeting
cyclin D1 and Ets1. PLoS One. 8:e557192013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu FL, Li YL, Wang ZD and Feng YJ:
Expression and significance about VEGF, KDR, MMP-1, and
transcription factor Ets-1 in human cervical carcinoma. Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 25:396–400. 2003.(In Chinese). PubMed/NCBI
|
|
36
|
Fujimoto J, Aoki I, Toyoki H, Khatun S and
Tamaya T: Clinical implications of expression of ETS-1 related to
angiogenesis in uterine cervical cancers. Ann Oncol. 13:1598–1604.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tomar S, Plotnik JP, Haley J, Scantland J,
Dasari S, Sheikh Z, Emerson R, Lenz D, Hollenhorst PC and Mitra AK:
ETS1 induction by the microenvironment promotes ovarian cancer
metastasis through focal adhesion kinase. Cancer Lett. 414:190–204.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu M, Liu X, Jin W, Li Y, Li Y, Hu Q, Chu
PK, Tang G and Ping Y: Targeting ETS1 with RNAi-based
supramolecular nanoassemblies for multidrug-resistant breast cancer
therapy. J Control Release. 253:110–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang SY, Lu ZM, Lin YF, Chen LS, Luo XN,
Song XH, Chen SH and Wu YL: miR-144-3p, a tumor suppressive
microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
Oncotarget. 7:11637–11650. 2016.PubMed/NCBI
|
